Introduction
The incidence of hip fractures in the elderly population is on the rise. It has been increasing by 2 percent yearly from 1999 to 2006, and a continual increment is predicted [1]. The incidence of hip fractures worldwide is estimated to be 2.6 million in 2025 and 4.5 million by 2050 [2]. It is important to note that the population is ageing. On initial presentation, a significant proportion of patients with hip fractures have other associated medical co-morbidities. Surgical intervention is the mainstay treatment for most patients. Comprehensive care is provided by multidisciplinary team approach including the medical team to optimise the patient medically prior to surgery, as required, to improve patients' outcomes. Delay to surgery has been associated with increased morbidity and mortality in hip fracture patients.
In our department, all hip fracture patients with newly